Giuseppe Orlando to Liver Cirrhosis
This is a "connection" page, showing publications Giuseppe Orlando has written about Liver Cirrhosis.
Connection Strength
0.314
-
Orlando G, Lai Q, Lerut J. Composite hepatocellular and hemangiosarcomatous tumor: The prognosis is determined by the sarcomatous component. Hepatobiliary Pancreat Dis Int. 2020 Apr; 19(2):184-186.
Score: 0.168
-
Manzia TM, Angelico R, Baiocchi L, Toti L, Ciano P, Palmieri G, Angelico M, Orlando G, Tisone G. The Tor Vergata weaning of immunosuppression protocols in stable hepatitis C virus liver transplant patients: the 10-year follow-up. Transpl Int. 2013 Mar; 26(3):259-66.
Score: 0.103
-
Manzia TM, Bellini MI, Corona L, Toti L, Fratoni S, Cillis A, Orlando G, Tisone G. Successful treatment of systemic de novo sarcoidosis with cyclosporine discontinuation and provision of rapamune after liver transplantation. Transpl Int. 2011 Aug; 24(8):e69-70.
Score: 0.023
-
Lerut J, Mathys J, Verbaandert C, Talpe S, Ciccarelli O, Lemaire J, Bonaccorsi-Riani E, Vanthuyne V, Hetsch N, Roggen F, Reyck CD, Goffette P, Latinne D, Orlando G, Rahier J, Sempoux C, Wallemacq P, Laterre PF, Gianello P. Tacrolimus monotherapy in liver transplantation: one-year results of a prospective, randomized, double-blind, placebo-controlled study. Ann Surg. 2008 Dec; 248(6):956-67.
Score: 0.020